Skip to content

InvestorsNASDAQ: ANIX

Stock SEC Filings

Back to anixa.com

Corporate deck Contact Investor FAQs

Loading…

NASDAQ: ANIXBack to anixa.com

Company

Overview
Leadership
Governance
Contact

Investors

Press Releases
Events & Webcasts
Stock Information
SEC Filings

Resources

Presentations
Email Alerts
Investor FAQs

Anixa Biosciences, Inc. uses its investor relations website as a recognized channel for disclosing material, non-public information and for complying with its disclosure obligations under Regulation FD. Investors should monitor this site, along with the company's press releases, SEC filings, and public conference calls and webcasts.

© 2026 Anixa Biosciences, Inc.Privacy Terms Accessibility

Site by Front Yard and Crescendo Communications

We use cookies to power embedded market data and to remember your alert preferences. You can decline non-essential cookies.

SEC filings

View company page on EDGAR

All filings Annual Quarterly Current (8-K)Proxy Registration Insider buying/selling

Year

All years

All years 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2007 2006 2005 2004

FiledFormReporting personTransactionAmount

Sep 18, 2018
4
Kumar Amit
Director, Chief Executive Officer
- POpen-market purchase+3,000
↗
Sep 17, 2018
4
Titterton Lewis H Jr
Director
- POpen-market purchase+5,000
↗
Sep 14, 2018
4
Kumar Amit
Director, Chief Executive Officer
- POpen-market purchase+3,000
↗
Sep 13, 2018
4
Kumar Amit
Director, Chief Executive Officer
- POpen-market purchase+4,112
↗
Sep 12, 2018
4
Kumar Amit
Director, Chief Executive Officer
- POpen-market purchase+4,480
↗
Apr 11, 2018
4
Williams Richard H
Director
- SOpen-market sale−25,000
↗
Oct 23, 2017
4
Titterton Lewis H Jr
Director
- MOption exercise+2,400
- MOption exercise−2,400
↗
Jun 06, 2017
4
Kumar Amit
Director
- POpen-market purchase+10,000
↗
Jun 05, 2017
4
Berman Robert Andrew
Director, President & CEO
- POpen-market purchase+100
- POpen-market purchase+9,900
↗
Jun 05, 2017
4
Kumar Amit
Director
- POpen-market purchase+500
- POpen-market purchase+1,422
- POpen-market purchase+8,078
↗
Oct 24, 2016
4
Herms Henry P
VP, Finance & CFO
- MOption exercise+2,000
- DDisposition to issuer−804
- MOption exercise−2,000
↗
Aug 26, 2016
4
Titterton Lewis H Jr
Director
- SOpen-market sale−210,000
↗
Jul 05, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+4,500
↗
Jun 29, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+400
↗
Jun 20, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+200
- POpen-market purchase+200
↗
Jun 13, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+900
↗
Jun 10, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+500
↗
Jun 06, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+1,500
- POpen-market purchase+500
↗
Jun 03, 2016
4
Herms Henry P
V.P., Finance & CFO
- MOption exercise+2,000
- SOpen-market sale−1,000
- SOpen-market sale−500
- SOpen-market sale−500
- MOption exercise−2,000
↗
Jun 01, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+100
- POpen-market purchase+2,504
↗
Apr 21, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+100
- POpen-market purchase+200
- POpen-market purchase+200
↗
Apr 11, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+200
↗
Apr 04, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+500
- POpen-market purchase+100
↗
Mar 30, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+100
↗
Mar 25, 2016
4
Johnson Bruce F
Director
- POpen-market purchase+720
↗

PreviousPage 5 of 11Next